Efficacy and Safety of Thrombin-Receptor Antagonist (Atopaxar and Vorapaxar) in Patients with Acute Coronary Syndrome or Coronary Artery Disease-A Meta-Analysis of Randomized Controlled Trials.

Gao, Lan; Zhao, Fei-Li; Li, Shu-Chuen

Gao, Lan; Zhao, Fei-Li; Li, Shu-Chuen.

Afiliação

Gao L; School of Biomedical Sciences and Pharmacy, The University of Newcastle, Newcastle, Callaghan, NSW, Australia; Deakin Health Economics, Population Health Strategic Research Centre, Faculty of Health, Deakin University, Melbourne, VIC, Australia.
Zhao FL; Access and Public Affair, Pfizer Australia, Sydney, NSW, Australia.
Li SC; School of Biomedical Sciences and Pharmacy, The University of Newcastle, Newcastle, Callaghan, NSW, Australia. Electronic address: ShuChuen.Li@newcastle.edu.au.

Value Health Reg Issues ; 6: 22-32, 2015 May.

Article em En | MEDLINE | ID: mdl-29698189

Palavras-chave

acute coronary syndrome; coronary artery disease; meta-analysis; randomized controlled trials; thrombin-receptor antagonist

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Systematic_reviews Idioma: En Revista: Value Health Reg Issues Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Austrália

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google